W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
Heart hole closer tested to stop strokes
Disease control OngoingThis study looks at a device that closes a small hole in the heart (called PFO) to help prevent strokes in people who have had a stroke with no clear cause. About 300 people in Japan will be followed for 12 months after the procedure. The main goal is to see if the device safely …
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New stent aims to fix deadly aortic bulges without open surgery
Disease control OngoingThis study tests a new stent device (GORE EXCLUDER TAMBE) to treat thoracoabdominal and pararenal aortic aneurysms—dangerous bulges in the main artery. About 102 to 202 participants will receive the stent via a minimally invasive procedure. The goal is to see if the device can sa…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New implant offers hope for glaucoma patients failing drops
Disease control OngoingThis early study tests a new device called the GORE Glaucoma Drainage Implant in 30 adults with primary open-angle glaucoma that eye drops cannot control or who are at high risk of scarring from standard surgery. The goal is to see if the implant safely lowers eye pressure by at …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New stent graft approved for life-threatening aortic aneurysms
Disease control APPROVED_FOR_MARKETINGThis study looks at a special device called the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis for treating aneurysms in the chest and belly area. These aneurysms are bulges in the main blood vessel that can burst if not treated. The device is placed inside the blood vessel…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New stent graft could fix Life-Threatening aortic tears without open surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a device called the GORE Ascending Stent Graft to treat serious conditions of the ascending aorta, such as aneurysms (bulging blood vessels), dissections (tears), and ulcers. The goal is to repair these lesions using a less invasive procedure instead of open-hear…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Hernia mesh under the microscope: 5-Year study tracks recurrence and safety
Disease control OngoingThis study follows 320 people who had ventral or incisional hernia repair using GORE SYNECOR mesh. Researchers track hernia recurrence, infections, and other complications over 5 years. The goal is to see how well the mesh works in real-world use, not to cure the hernia but to im…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New stent graft device under Real-World scrutiny for aortic aneurysm repair
Disease control ENROLLING_BY_INVITATIONThis study tracks 300 people who receive a special stent graft to treat aneurysms in the abdomen or chest area. The goal is to confirm the device works well and is safe in everyday medical practice. Participants are followed for a year to check for complications like leaks, block…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New stent aims to open blocked veins and ease leg pain
Disease control OngoingThis study tests a special stent (a small mesh tube) to treat blockages in the large vein that returns blood from the lower body to the heart. About 136 adults with symptoms like leg swelling, pain, or ulcers will receive the stent and be followed for a year. The goal is to see i…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
New stent-graft aims to fix deadly aortic tears without open surgery
Disease control OngoingThis study tests a new device (GORE TAG TBE) to treat weak spots or tears in the main artery of the chest. It involves 250 adults who need repair in a specific area (Zone 2). The device is placed through a small tube in a blood vessel, avoiding open surgery, and aims to safely se…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New heart valve device offers hope for patients with congenital defects
Disease control OngoingThis study is testing a new device called the GORE PV1 to replace the pulmonary valve and rebuild the right ventricular outflow tract in people with congenital heart defects. The device is designed to improve blood flow from the heart to the lungs. The study includes 15 participa…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 02, 2026 11:39 UTC
-
Massive global study monitors aortic stent safety in 4,600 patients
Knowledge-focused OngoingThis study is a large registry that collects real-world information on how well Gore aortic stent grafts work and what complications may occur. It follows about 4,600 people who need a minimally invasive repair of an aortic aneurysm or other aortic condition. The goal is to track…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
New registry monitors VBX stent graft in Real-World use
Knowledge-focused OngoingThis study is a registry that collects safety and performance data on the GORE® VIABAHN® VBX Stent Graft when used in peripheral vessels. It involves 280 adults who need this device to treat peripheral vascular disease. The goal is to see how well the stent graft works and if the…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Worldwide registry monitors artery stent safety in thousands of patients
Knowledge-focused OngoingThis study collects information from over 600 patients who have already received the GORE VIABAHN stent-graft for conditions like peripheral artery disease, aneurysms, or trauma. The goal is to track how often serious device-related problems occur in everyday medical practice. No…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC